Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Example of Drug Shortage Information and Links
National Resources:
FDA Drug Shortages & Discontinuations
Rpharmy Memorial Drug Shortage Information:
| Resolved Shortages | |
| None | |
| Drug Products on Critical Shortage | |
| Drug Name | Details |
| colistin/HC/neomycin/thonzonium otic | Supply in pharmacy is critical. Estimated release: Sep 2024 |
| diphenoxylate-atropine oral liquid | Supply of the oral suspension for pharmacy is critical. Estimated release: none. Tablet supply is unaffected. |
| isosorbide mononitrate IR tablets | Supply is critical in pharmacy. Estimated release: none. Extended-release products are currently unaffected. |
| methylprednisolone 2 mg tablets | Supply in pharmacy is depleted. Estimated release: May 2025 |
| Rho(D) immune globulin | Supply in pharmacy is critical. Estimated release: periodic and unpredictable throughout 2024. |
| Vitamin A palmitate injection | Supply in pharmacy is depleted. Estimated release: Aug 2024 |
| Drug Products on Shortage - Limited Availability | |
| Drug Name | Details |
| sodium bicarbonate injectable |
Supply of manufacturer 50ml syringes is limited in pharmacy; 10ml syringes are depleted. Vial supply is unaffected. Estimated release for 10ml syringes: Jan 2026. |
| Relevant Products on National Shortage – No Practice Changes Needed | |
| Drug Name | Details |
| basiliximab injectable | Pharmacy has adequate supply to meet needs. |
| dextrose 50% injectable | Pharmacy has adequate supply to meet needs. |
| epoprostenol inhalation | Pharmacy has adequate supply to meet needs. |
| nystatin oral suspension | Pharmacy has adequate supply to meet needs. |
| penicillin G benzathine injectable | Pharmacy has adequate supply to meet needs. |
| remifentanil injectable | Pharmacy has adequate supply to meet needs. |
| rifaximin 200 mg tablets | Pharmacy has adequate supply to meet needs. |
| Discontinued (no longer being manufactured) | |
| Drug Name | Notes/Information |
| activated charcoal pellets | Supply in pharmacy is critical. All pellet charcoal products have been discontinued. |
| lindane products | All presentations have been discontinued FDA Orange Book |
| mafenide acetate powder for solution |
All topical solutions have been discontinued FDA Orange Book |
| methyldopa tablet |
All presentations have been discontinued FDA Orange Book |
| nicotine inhalation system |
|
| testosterone transdermal patches | All presentations have been discontinued FDA Orange Book |